Enfoque de la paciente embarazada con enfermedad valvular cardiaca

  • Ana G. Múnera Universidad Pontificia Bolivariana
Palabras clave: embarazo, enfermedad valvular, prótesis valvulares, anticoagulación

Resumen

Las mujeres con enfermedad valvular que están embarazadas o planean embarazarse requieren cuidadosa evaluación y manejo. El embarazo se asocia con cambios fisiológicos que pueden agravar muchas enfermedades valvulares. La mayoría de mujeres toleran bien el embarazo y el parto sin complicaciones mayores; sin embargo, algunos tipos de enfermedad valvular son mal tolerados y requieren manejo intensivo. Además las pacientes con riesgo de tromboembolismo y aquellas con prótesis valvulares requieren anticoagulación y la decisión respecto al tipo e intensidad de la anticoagulación, requiere un cuidadoso balance entre el riesgo individual de trombosis y sangrado en la madre y los peligros para el feto. La clave para optimizar los buenos resultados en las pacientes con enfermedad valvular cardiaca consiste en un diagnóstico exacto de la etiología, en la clasificación del riesgo, en la adecuada evaluación y consejería antes de la gestación y la referencia de las mujeres de alto riesgo a centros con experiencia. El manejo de estas pacientes debe ser multidisciplinario con un equipo que incluya especialistas en las áreas de obstetricia, cardiología, neonatología y anestesiología entre otros.

Biografía del autor/a

Ana G. Múnera, Universidad Pontificia Bolivariana

Medicina Interna-Cardiología Universidad Pontificia Bolivariana, Cardiología No Invasiva Universidad CES. Cardiología No Invasiva Hospital General de Medellín “Luz Castro de Gutiérrez”.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Ana G. Múnera, Universidad Pontificia Bolivariana

Medicina Interna-Cardiología Universidad Pontificia Bolivariana, Cardiología No Invasiva Universidad CES. Cardiología No Invasiva Hospital General de Medellín “Luz Castro de Gutiérrez”.

Citas

Siu S C, Sermer M, Colman J M, Alvarez N et al. Prospective Multicenter Study of Pregnancy Outcomes in Women with Heart Disease. Circulation. 2001;104:515-21.

Siu S C, Colman J M, Sorensen S et al. Adverse Neonatal And Cardiac Outcomes Are More Common In Pregnant Women With Cardiac Disease. Circulation. 2002;105:2179-84.

Stout K, Otto C. Pregnancy In Women With Valvular Heart Disease. Heart. 2007;93:552–558.

Scirica B, O’Gara P. Valvular Heart Disease In Pregnancy. Current Cardiology Reports. 2006;8:83–89.

Gei A, Hankins G. Medical Complications of Pregnancy. Cardiac Disease And Pregnancy. Obstetrics ang Gynecology Clinics of North America. 2001;28(3):465-512.

Van Oppen A C, Stigter R H, Bruinse H W. Cardiac Output In Normal Pregnancy: a Critical Review. Obstetrics and Gynaecology. 1996;87:310–18.

Easterling T R, Carlson K L, Schmucker B C et al. Measurement Of Cardiac Output In Pregnancy By Doppler Technique. American Journal of Perinatology. 1990;7:220–2.

Robson S C, Hunter S, Moore M et al. Haemodynamic Changes During The Puerperium: a Doppler And M-mode Echocardiographic Study. British Journal of Obstetrics and Gynaecology. 1987;94:1028–39.

Easterling T R, Benedetti T J, Schmucker B C et al. Maternal Hemodynamics In Normal And Preeclamptic Pregnancies: A Longitudinal Study. Obstetrics and Gynecology. 1990;76:1061–9.

De Boer K, Cate J W, Sturk A, Borm J J, Treffers P E. Enhanced Thrombin Generation In Normal And Hypertensive Pregnancy. American Journal of Obstetrics and Gynecology. 1989;160:95– 00.

Immer F F, Bansi A G, Immer-Bansi A S et al. Aortic Dissection In Pregnancy: Analysis Of Risk Factors And Outcome. The Annals of Thoracic Surgery. 2003;76:309 –14.

Bryant-Greenwood G D, Schwabe C. Human Relaxins: Chemistry And Biology. Endocrine Reviews. 1994;15:5–26.

Warnes C. Pregnancy And Heart Disease. In Braunwald E. Heart disease. A textbook of cardiovascular medicine. 8th ed. Philadelphia. Saunders W B. 2007:p1967

Bonow R, Carabello B, Chatterjee K et al. 2008 Focused Update Incorporated lIn To The ACC/AHA 2006. Guidelines For The Management Of Patients With Valvular Heart Disease. Circulation. 2008;118:523-661.

Silversides C, Colman J. Physiological Changes In Pregnancy. In Oakley C, Warnes C. Heart Diseases In Pregnancy. 2nd ed. Blackwell Publishing. 2007.p6.

Nihoyannopoulos P. Cardiovascular Examination in Pregnancy and the Approach to Diagnosis of Cardiac Disorder. In Oakley C, Warnes C. Heart Diseases in Pregnancy. 2nd ed. Blackwell Publishing. 2007. p18.

Oakley C, Chile A, Jung B et al. Expert Consensus Document of Cardiovascular Diseases During Pregnancy. The Task Force On The Management Of Cardiovascular Diseases During Pregnancy Of The European Society Of Cardiology. European Heart Journal. 2003;24:761-781.

Reimold S, Rutherford D. Valvular Heart Disease in Pregnancy. New England Journal Of Medicine. 2003;349:52-9.

American Thoracic Society/American College of Chest Physicians. Statement On Cardiopulmonary Exercise Testing. American Journal of Respiratory and Critical Care Medicine. 2003;167:211–77.

Qasqus S A, McPherson C, Frishman W H, Elkayam U. Cardiovascular Pharmacotherapeutic Considerations During Pregnancy and Lactation. Cardiology in Review. 2004;12:201–21.

Hameed A, Karaalp I S, Tummala P et al. The Effect of Valvular Heart Disease on Maternal and Fetal Outcome of Pregnancy. Journal of the American College of Cardiology. 2001;37:893–9.

Silversides C K, Colman J M, Sermer M, Siu S C. Cardiac Risk in Pregnant Women With Rheumatic Mitral Stenosis. American Journal of Cardiology. 2003;91:1382–5.

Zelop C, Heffner L F. The Downside of Cesarean Delivery: Short- and Long-term Complications. Clinical Obstetrics and Gynecology. 2004;47:386 –93.

Elkayam U, Gleicher N. Hemodynamics and Cardiac Function During Normal Pregnancy and The Puerperium. In: Elkayam U, Gleicher N. Editors. Cardiac Problems in Pregnancy. New York, NY: Wiley-Liss. 1998;3–22.

Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a Guideline From The American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation2007;116:1736–54.

Baddour L M, Bettmann MA, Bolger A F et al. Nonvalvular cardiovascular device-related infections. Circulation 2003;108:2015–31.

Warnes C A, Williams R G, Bashore T M et al. ACC/AHA. 2008. Guidelines For The Management of Adults With Congenital Heart Disease: A Report of The American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease). Journal of The American College of Cardiology. 2008.

Elkayam U, Bitar F. Valvular Heart Disease and Pregnancy. Part I: Native Valves. Journal of The American College of Cardiology. 2005;46:223–230.

Boggess K A, Watts D H, Hillier S L et al. Bacteremia Shortly After Placental Separation During Cesarean Delivery. Obstetrics and Gynaecology. 1996;87:779–784.

Campuzano K, Roque H, Bolnick A et al. Bacterial Endocarditis Complicating Pregnancy: Case Report and Systematic Review of the Literature. Archives of Gynecology and Obstetrics. 2003, 268:251–255.

Hameed A, Karaalp I S, Tummala P P et al. The Effect of Valvular Heart Disease on Maternal and Fetal Outcome of Pregnancy. Journal of the American College of Cardiology. 2001, 37:893–899.

Silversides C K, Colman J M, Sermer M, Siu S C. Cardiac Risk in Pregnant Women With Rheumatic Mitral Stenosis. American Journal of Cardiology. 2003;91:1382–1385. 33. Barbosa PJ, Lopes AA, Feitosa GS et al. Prognostic Factors of Rheumatic Mitral Stenosis During Pregnancy and Puerperium. Arquivos Brasileiros de Cardiologia 2000;75:215–224.

Weiss B M, Von Segesser L K, Alon E et al. Outcome of Cardiovascular Surgery and Pregnancy: A Systematic Review of the Period 1984–1996. American Journal of Obstetrics and Gynecology. 1998;179:1643–1653.

De Souza J A, Martinez E E Jr, Ambrose J A et al. Percutaneous Balloon Mitral Valvuloplasty in Comparison with Open Mitral Valve Commissurotomy for Mitral Stenosis During Pregnancy. Journal of the American College of Cardiology. 2001;37:900–903.

Reimold S C, Rutherford J D. Clinical Practice. Valvular Heart Disease in Pregnancy. New England Journal Of Medicine. 2003, 349:52–59.

Bernard L. Mitral Valve Prolapsed. In Oakley C, Warnes C. Heart Diseases in Pregnancy. 2 ed. Blackwell Publishing. 2007. p96.

Lao T T, Adelman A G, Sermer M, Colman J M. Balloon Valvuloplasty for Congenital Aortic Stenosis n Pregnancy. British Journal Obstetrics and Gynecology. 1993;100:1141–2.

Banning A P, Pearson J F, Hall R J. Role of Balloon Dilatation of the Aortic Valve in Pregnant Patients with Severe Aortic Stenosis. British Heart Journal. 1993;70:544–5.

Otto C M. Timing of Aortic Valve Surgery. Heart. 2000;84:211– 218.

Mohler E R III. Mechanisms of Aortic Valve Calcification. American Journal of Cardiology. 2004;94:1396–1402.

Sheikh F, Rangwala S, DeSimone C, Smith HS, O’Leary A M. Management of the Parturient With Severe Aortic Incompetence. Journal of Cardiothoracic and Vascular Anesthesia. 1995;9:575–7.

Veldtman G R, Connolly H M, Grogan M et al. Outcomes of Pregnancy in Women with Tetralogy of Fallot. Journal of the American College of Cardiology. 2004;44:174–80.

Meijer J M, Pieper P G, Drenthen W et al. Pregnancy, Fertility, and Recurrence Risk in Corrected Tetralogy of Fallot. Heart. 2005;91:801–5.

Thorne S A. Congenital Heart Disease, Pregnancy in the Heart Disease. Heart. 2004;90:450-456

Sadler L, McCowan L, White H et al. Pregnancy Outcomes and Cardiac Complications in Women with Mechanical, Bioprosthetic and Homograft Valves. An International Journal of Obstetrics and Gynaecology. 2000;107:245–253.

Trimm J, Hung L, Rahimtoola S. Artificial heart valves. En: Oakley C, Warnes C. Heart diseases in pregnancy. 2 ed. Blackwell Publishing. 2007:104.

Salazar E, Espinola N, Roman L, Casanova J M. Effect of Pregnancy on the Duration of Bovine Pericardial Bioprostheses. American Heart Journal. 1999;137:714–720.

Sbarouni E, Oakley C M. Outcome of Pregnancy in Women with Valve Prostheses. British Heart Journal. 1994;71:196–201.

Hung L, Rahimtoola S H. Prosthetic Heart Valves and Pregnancy. Circulation 2003;107:1240–6.

Wong V, Cheng C H, Chan K C. Fetal and Neonatal Outcome of Exposure to Anticoagulants during Pregnancy. American Journal of Medical Genetics. 1993;45:17-21.

Hirsh J, Fuster V, Ansell J, Halperin J L. American Heart Association/ American College of Cardiology Foundation Guide to Warfarin Therapy. Journal of The American College of Cardiology. 2003;41:1633–52.

Hirsh J, Fuster V. Guide to Anticoagulant Therapy, Part 2. Oral Anticoagulants. American Heart Association. Circulation. 1994;89:01469–80.

Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of Adjusted Doses of Subcutaneous Heparin to Prevent Thromboembolic Phenomena in Pregnant Patients with Mechanical Cardiac Valve Prostheses. Journal of the American College of Cardiology. 1996;27:1698–703.

Ginsberg J S, Hirsh J. Use of Antithrombotic Agents during Pregnancy. Chest. 1995;108:305S–11S.

Elkayam U R. Anticoagulation in Pregnant Women with Prosthetic Heart Valves: a Double Jeopardy. Journal of the American College of Cardiology. 1996;27:1704–6.

Ginsberg J S, Chan W S, Bates S M, Kaatz S. Anticoagulation of Pregnant Women with Mechanical Heart Valves. Archives of Internal Medicine. 2003;163:694–8.

Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology European Heart Journal (2007) 28, 230–268.

Cómo citar
Múnera, A. G. (2010). Enfoque de la paciente embarazada con enfermedad valvular cardiaca. Revista Med, 18(1), 44-57. https://doi.org/10.18359/rmed.1290
Publicado
2010-06-30
Sección
Artículos